Literature DB >> 20011082

The diabetic foot: a global threat and a huge challenge for Greece.

N Papanas1, E Maltezos.   

Abstract

The diabetic foot continues to be a major cause of morbidity, posing a global threat. Substantial progress has been now accomplished in the treatment of foot lesions, but further improvement is required. Treatment options may be classified into established measures (revascularisation, casting and debridement) and new modalities. All therapeutic measures should be provided by specialised dedicated multidisciplinary foot clinics. In particular, the diabetic foot is a huge challenge for Greece. There is a dramatic need to increase the number of engaged foot care teams and their resources throughout the country. It is also desirable to continue education of both physicians and general diabetic population on the magnitude of the problem and on the suitable preventative measures. At the same time, more data on the prevalence and clinical manifestations of the diabetic foot in Greece should be carefully collected. Finally, additional research should investigate feasible ways of implementing current knowledge in everyday clinical practice.

Entities:  

Keywords:  amputations; diabetes mellitus; diabetic foot; diabetic neuropathy; peripheral arterial disease; ulceration

Year:  2009        PMID: 20011082      PMCID: PMC2776331     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  48 in total

1.  Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients.

Authors:  E Faglia; G Clerici; J Clerissi; L Gabrielli; S Losa; M Mantero; M Caminiti; V Curci; T Lupattelli; A Morabito
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-05-26       Impact factor: 7.069

2.  Diagnosis and treatment of diabetic foot infections.

Authors:  Benjamin A Lipsky; Anthony R Berendt; H Gunner Deery; John M Embil; Warren S Joseph; Adolf W Karchmer; Jack L LeFrock; Daniel P Lew; Jon T Mader; Carl Norden; James S Tan
Journal:  Plast Reconstr Surg       Date:  2006-06       Impact factor: 4.730

Review 3.  Emerging drugs for diabetic foot ulcers.

Authors:  Nina Petrova; Michael Edmonds
Journal:  Expert Opin Emerg Drugs       Date:  2006-11       Impact factor: 4.191

4.  Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients.

Authors:  N Papanas; K Papatheodorou; D Christakidis; D Papazoglou; G Giassakis; H Piperidou; C Monastiriotis; E Maltezos
Journal:  Exp Clin Endocrinol Diabetes       Date:  2005-04       Impact factor: 2.949

5.  Evaluation of the self-administered indicator plaster neuropad for the diagnosis of neuropathy in diabetes.

Authors:  Nicholas Tentolouris; Vasilis Achtsidis; Kyriaki Marinou; Nicholas Katsilambros
Journal:  Diabetes Care       Date:  2007-11-19       Impact factor: 19.112

6.  Lipid peroxides in type 2 diabetic patients with neuropathy.

Authors:  I N Migdalis; P Triantafilou; E Petridou; N Varvarigos; V Totolos; A Rigopoulos
Journal:  Res Commun Mol Pathol Pharmacol       Date:  2005

Review 7.  Vascular evaluation and arterial reconstruction of the diabetic foot.

Authors:  Bauer E Sumpio; Taeseung Lee; Peter A Blume
Journal:  Clin Podiatr Med Surg       Date:  2003-10       Impact factor: 1.231

Review 8.  The diabetic foot: grand overview, epidemiology and pathogenesis.

Authors:  Andrew J M Boulton
Journal:  Diabetes Metab Res Rev       Date:  2008 May-Jun       Impact factor: 4.876

9.  Sudomotor dysfunction is associated with foot ulceration in diabetes.

Authors:  N Tentolouris; K Marinou; P Kokotis; A Karanti; E Diakoumopoulou; N Katsilambros
Journal:  Diabet Med       Date:  2009-03       Impact factor: 4.359

10.  Painful neuropathy and foot ulceration in diabetic patients.

Authors:  A Veves; C Manes; H J Murray; M J Young; A J Boulton
Journal:  Diabetes Care       Date:  1993-08       Impact factor: 19.112

View more
  6 in total

1.  (18)F-FDG PET and PET/CT for the diagnosis of diabetic foot osteomyelitis.

Authors:  N Papanas; A Zissimopoulos; E Maltezos
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

2.  Greek financial crisis: consequences in the healthcare of diabetes and its complications.

Authors:  K Aloumanis; N Papanas
Journal:  Hippokratia       Date:  2014-01       Impact factor: 0.471

3.  The role of nerve growth factor in the prophylaxis and treatment of diabetic foot ulcers.

Authors:  Elisavet K Tiaka; Nikolaos Papanas; Anastassios C Manolakis; Efstratios Maltezos
Journal:  Int J Burns Trauma       Date:  2011-09-03

4.  Etiology, pathophysiology and classifications of the diabetic Charcot foot.

Authors:  Nikolaos Papanas; Efstratios Maltezos
Journal:  Diabet Foot Ankle       Date:  2013-05-21

5.  Determinants of microbial load in infected diabetic foot ulcers: a pilot study.

Authors:  M Demetriou; N Papanas; M Panopoulou; K Papatheodorou; E Maltezos
Journal:  Int J Endocrinol       Date:  2013-06-26       Impact factor: 3.257

Review 6.  Therapeutic application of adipose-derived stromal vascular fraction in diabetic foot.

Authors:  Xiansheng Zhao; Jiamin Guo; Fangfang Zhang; Jue Zhang; Delin Liu; Wenjun Hu; Han Yin; Liang Jin
Journal:  Stem Cell Res Ther       Date:  2020-09-14       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.